Effects of Administration of Growth Hormone, Without and With Liraglutide, on AgRP, Energy and Glucose Metabolism in Healthy and GH Deficient Humans

Registration

Registration

NCT05681299

Study type

INTERVENTIONAL

Allocation

RANDOMIZED

Phase

PHASE4

Masking

SINGLE

Status

RECRUITING

Enrollment

40

Start

2023-05-01

Primary completion

2028-04-30

Lead sponsor

Columbia University

Conditions

Healthy; Growth Hormone Deficiency

Interventions

DRUG:growth hormone and lirglutide; DRUG:growth hormone; DRUG:liraglutide; DRUG:Placebo

Results posted

FALSE

Individual participant data sharing

NO

Registered primary outcomes

• AgRP change in GH vs. placebo arms [Baseline to weeks 1, 2, 3 of each study arm.]
• AgRP change in GH vs. GH + liraglutide arms [Baseline to weeks 1, 2, 3 of each study arm.]